FDA-ZINC08101196

MMsINC code: MMs01727747

• Type: Neutral
• Formula: C₄₁H₆₇NO₁₅
• SMILES: O1C(C)C(C)C(OC(=O)C)C(C)C(=O)C2(OC2)CC(C)C(OC2OC(CC(N(C)C)C2OC(=O)C)C)C(C)C(OC2OC(C)C(OC(=O)C)C(OC)C2)C(C)C1=O
• InChI: InChI=1/C41H67NO15/c1-19-17-41(18-49-41)38(46)23(5)34(53-27(9)43)21(3)25(7)52-39(47)24(6)35(56-32-16-31(48-14)36(26(8)51-32)54-28(10)44)22(4)33(19)57-40-37(55-29(11)45)30(42(12)13)15-20(2)50-40/h19-26,30-37,40H,15-18H2,1-14H3/t19-,20+,21-,22-,23-,24-,25+,26+,30+,31+,32-,33-,34-,35-,36-,37+,40+,41-/m1/s1

Potential Energy
Epot(MMFF94)=144.436 kcal/mol

MOE's Descriptors

Physical Properties

• Molecular Weight: 813.979 g/mol
• logS: -5.65214
• SlogP: 3.6209
• Reactive groups: 1

Topological Properties

• Globularity: 0.215924
• Sterimol/B1: 3.94266
• Sterimol/B2: 4.85271
• Sterimol/B3: 8.00072
• Sterimol/B4: 10.0376
• Sterimol/L: 22.0402

Surface and Volume Properties

• Accessible surface: 1022.71
• Positive charged surface: 749.047
• Negative charged surface: 273.668
• Volume: 794.5
• Hydrophobic surface: 828.292
• Hydrophilic surface: 194.418

Pharmacophoric Properties

• Hydrogen bond donors: 0
• Hydrogen bond acceptors: 12
• Acid groups: 0
• Basic groups: 0
• Chiral centers: 18

Drug- and Lead-like Properties

• Lipinski's drug-like rule: 0
• Violations of Lipinski's rule: 2
• Oprea's lead like rule: 0